Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1

XW04351 ICD10-PCS Code is a billable and specific code that can be used to indicate the procedure of Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1 for reimbursement purposes. The 2023 edition of the American ICD-10-PCS code became effective on October 1, 2022.

Short description for XW04351 ICD10-PCS code:

Introduce Blinatumomab in Central Vein, Perc, New Tech 1